Vicarious Surgical (RBOT) Q4 2025 earnings summary

Executive summary

• Operating expenses decreased 38% year-over-year in Q4 2025 and 25% for the full year 2025.

• Net loss narrowed to $10.5M in Q4 2025 from $13.9M in Q4 2024; full year net loss was $50.2M, down from $63.2M in 2024.

• Cash and investments totaled $9.8M at year-end 2025, with a cash burn of $45.1M, below guidance.

Financial highlights

• Research and development expenses fell 16% year-over-year in both Q4 and full year 2025.

• General and administrative expenses dropped 53% in Q4 and 31% for the year compared to 2024.

• Sales and marketing expenses declined 56% in Q4 and 52% for the year.

• Adjusted net loss for Q4 2025 was $11.1M ($1.65/share), down from $14.4M ($2.43/share) in Q4 2024.

• Adjusted net loss for full year 2025 was $51.0M ($8.31/share), down from $63.3M ($10.75/share) in 2024.

Outlook and guidance

• 2026 cash burn is expected to be approximately $19M, a significant reduction from 2025.